HOME > TOP STORIES
TOP STORIES
-
REGULATORY Chuikyo Reps Raise No Opposition to Off-Year Re-Pricing, Still Split over Product Scope
December 3, 2020
-
REGULATORY MHLW to Issue Notification to Urge Drug Makers’ Prompt Info Provisioning on Supply Shortages
December 3, 2020
-
REGULATORY Average NHI-Market Price Gap at 8.0%: MHLW
December 2, 2020
-
BUSINESS Sanofi Japan to Sharpen Focus on Priority Pipelines as It Eyes Turnaround after 2022: President
December 1, 2020
-
BUSINESS Demand for Nesp Biosimilars Spiking as Hospitals Turn to Cheaper Meds in Dialysis Care, Shipment Control Triggered
December 1, 2020
-
REGULATORY MHLW Approves Label Expansions for Forxiga, Trelegy, Evrenzo, Cabometyx and More
November 30, 2020
-
REGULATORY Japan to Set New Generic Target by March-End: Health Minister
November 30, 2020
-
REGULATORY LDP Health Policy Clique Set to Urge Govt to Skip Off-Year Re-Pricing Next Year, but Explore Middle Ground at Same Time
November 27, 2020
-
REGULATORY MOF Panel Issues FY2021 Budget Recommendation, Ups Tone on All-Product Drug Re-Pricing
November 26, 2020
-
REGULATORY 3 Pharma Groups: Limit Scope of Off-Year Re-Pricing to Drugs with “Significantly Large Discrepancy Rates”
November 26, 2020
-
REGULATORY MHLW Scrambling to Set Up Vaccination System for Ultracold-Chain Required COVID-19 Vaccine
November 26, 2020
-
REGULATORY Ryukaikon Confab Held after 17 Month Hiatus, COVID-19 Impact on Drug Distribution Discussed
November 25, 2020
-
ACADEMIA Chugai’s Multigene Panel Test Difficult to Use as CDx, Reimbursement Rules Should Be Revised: KOL
November 25, 2020
-
BUSINESS Improved Hygiene amid COVID-19 Hit Infectious Disease Meds, Big-Seller Hopefuls See Slow Uptake
November 24, 2020
-
REGULATORY 1st Humira Biosimilar to Join NHI Price List on Nov. 25
November 24, 2020
-
BUSINESS Big 3 Generic Makers Log 7.2% Growth in 1st Half, Suffer Sluggish Japan Sales on Price Cuts, COVID-19: Jiho Tally
November 20, 2020
-
ORGANIZATION EFPIA Japan Chief Frets Declining Priority for Japan Market since 2018 Pricing Overhaul
November 19, 2020
-
ACADEMIA National Cancer Center Exploring Effectiveness of Frontline Use of Multigene Panel Testing for Solid Tumors
November 18, 2020
-
REGULATORY Drug Makers Disclosing as Much Cost Info as Possible in Price Negotiations, JPMA Chief Rebuts Concerns Aired in Project Review
November 17, 2020
-
REGULATORY With Consensus on 13 Topics Delayed by COVID-19, ICH Expected to Restrict Selection of New Topics at Virtual Assembly
November 16, 2020
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
